Astrana Health (ASTH) Current Deferred Revenue (2023 - 2025)

Astrana Health (ASTH) has 3 years of Current Deferred Revenue data on file, last reported at $2.7 million in Q4 2025.

• Quarterly Current Deferred Revenue rose 65.57% year-over-year to $2.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.7 million (up 65.57% YoY) and the FY2025 annual result came in at $2.7 million, up 65.57% from the prior year.
• Current Deferred Revenue grew to $2.7 million in Q4 2025 per ASTH's latest filing, from $686000.0 in the prior quarter.
• The five-year high for Current Deferred Revenue was $2.7 million in Q4 2025, with the low at $686000.0 in Q1 2025.
• Average Current Deferred Revenue over 3 years is $1.8 million, with a median of $1.9 million recorded in 2024.
• Year-over-year, Current Deferred Revenue soared 115.86% in 2024 and surged 65.57% in 2025.
• Astrana Health's Current Deferred Revenue stood at $744000.0 in 2023, then soared by 115.86% to $1.6 million in 2024, then surged by 65.57% to $2.7 million in 2025.
• Business Quant data shows ASTH's Current Deferred Revenue at $2.7 million in Q4 2025, $686000.0 in Q1 2025, and $1.6 million in Q4 2024.